Inventor · disambiguated record
Barbara Sennino
Also filed as: SENNINO BARBARA
8 granted patents·11 pending applications·10 citations·filing 2016–2025
80Inventor score
Top patents by PatentIndex Score
19 records- 0188US11304978B2Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapyPACT PHARMA INC·Filed 2020·Granted Apr 19, 2022·2 cites·24 claims
- 0286US10273281B2CD80 extracellular domain polypeptides and their use in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2016·Granted Apr 30, 2019·7 cites·40 claims
- 0378US12365719B2CD80 extracellular domain polypeptides and their use in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2022·Granted Jul 22, 2025·0 cites·18 claims
- 0477US11513113B2Compositions and methods for identification of antigen specific T cellsPACT PHARMA INC·Filed 2020·Granted Nov 29, 2022·1 cites·16 claims
- 0572US12276656B2Compositions and methods for identification of antigen specific T cellsADOC SSF LLC·Filed 2022·Granted Apr 15, 2025·0 cites·16 claims
- 0672US12247061B2Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapyADOC SSF LLC·Filed 2022·Granted Mar 11, 2025·0 cites·11 claims
- 0771US11098103B2CD80 extracellular domain polypeptides and their use in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2019·Granted Aug 24, 2021·0 cites·8 claims
- 0866US2024016844A1Methods of treatment using a genetically modified autologous t cell immunotherapyPACT PHARMA INC·Filed 2023·Application pending·0 cites
- 0965US2021085720A1Compositions and methods for the treatment of cancer using a tet2 engineered t cell therapyPACT PHARMA INC·Filed 2020·Application pending·0 cites
- 1064US2025244313A1Compositions and methods for identification of antigen specific t cellsADOC SSF LLC·Filed 2025·Application pending·0 cites
- 1160US2024066063A1COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER USING A TGFßRII ENGINEERED T CELL THERAPYPACT PHARMA INC·Filed 2023·Application pending·0 cites
- 1259US2023355762A1Compositions and methods for the treatment of cancer using next generation engineered t cell therapyPACT PHARMA INC·Filed 2023·Application pending·0 cites
- 1359US2024133886A1Methods of assessing cell productsADOC SSF LLC·Filed 2023·Application pending·0 cites
- 1458US2023136076A1Methods of determining gene editing eficiencies in cellsPACT PHARMA INC·Filed 2022·Application pending·0 cites
- 1558US2019194288A1Cd80 extracellular domain polypeptides and their use in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1655US11789010B2Methods of treatment with CD80 extracellular domain polypeptidesFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Oct 17, 2023·0 cites·20 claims
- 1755US2021205363A1Methods of treatment using a genetically modified autologous t cell immunotherapyPACT PHARMA INC·Filed 2020·Application pending·0 cites
- 1852US2022010274A1Personalized neoantigen-specific adoptive cell therapiesPACT PHARMA INC·Filed 2021·Application pending·0 cites
- 1949US2021106621A1Method of treating immunotherapy non-responders with an autologous cell therapyPACT PHARMA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Barbara Sennino files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →